Hot Stocks
Should You Invest in Irobot Corp (IRBT) Now?
The 36-month beta value for IRBT is at 0.76. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
© 2024, Powered by Smart TechOne
Menu
The 36-month beta value for IRBT is at 0.76. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
The stock of Coherus Biosciences Inc (CHRS) has seen a 0.92% increase in the past week, with a -30.17% drop in the past month, and
The stock of Arch Capital Group Ltd (NASDAQ: ACGL) has decreased by -0.95 when compared to last closing price of 92.85. Despite this, the company
Moreover, the 36-month beta value for VYGR is 0.88. Analysts have varying opinions on the stock, with 11 analysts rating it as a “buy,” 1
In the past week, EB stock has gone down by -2.16%, with a monthly gain of 7.08% and a quarterly plunge of -30.15%. The volatility
The stock price of Larimar Therapeutics Inc (NASDAQ: LRMR) has dropped by 0.00 compared to previous close of 1.93. Despite this, the company has seen
The price-to-earnings ratio for Riverview Bancorp, Inc (NASDAQ: RVSB) is above average at 25.30x. The 36-month beta value for RVSB is also noteworthy at 0.51.
The stock of Achieve Life Sciences Inc (ACHV) has gone up by 8.79% for the week, with a 22.22% rise in the past month and
The stock of Perimeter Solutions Inc (NYSE: PRM) has increased by 0.77 when compared to last closing price of 11.70. Despite this, the company has
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has a price-to-earnings ratio of 15.39x that is above its average ratio. Additionally, the 36-month beta value for CPRX is
© 2024, Powered by Smart TechOne